有恶意
发表于 2025-3-26 22:59:35
Springer Science+Business Media, LLC 2011
退出可食用
发表于 2025-3-27 01:28:08
Management of Cardiac Arrhythmias978-1-60761-161-5Series ISSN 2196-8969 Series E-ISSN 2196-8977
投票
发表于 2025-3-27 05:19:01
http://reply.papertrans.cn/63/6225/622454/622454_33.png
绝种
发表于 2025-3-27 09:48:14
http://reply.papertrans.cn/63/6225/622454/622454_34.png
Occipital-Lobe
发表于 2025-3-27 17:25:00
Renee M. Sullivan MD,Wei Wei Li MD,Arthur C. Kendig MD,Brian Olshansky M.D
deactivate
发表于 2025-3-27 21:14:04
http://reply.papertrans.cn/63/6225/622454/622454_36.png
矿石
发表于 2025-3-27 23:16:10
http://reply.papertrans.cn/63/6225/622454/622454_37.png
伙伴
发表于 2025-3-28 03:44:41
Ernest Matthew Quin MD,J. Marcus Wharton MD,Michael R. Gold MD, PHD
休战
发表于 2025-3-28 08:05:31
http://reply.papertrans.cn/63/6225/622454/622454_39.png
expunge
发表于 2025-3-28 11:27:42
Pharmacologic Management of Atrial Fibrillation and Flutterl strategy must be individualized based on patient characteristics. This chapter will review the considerations necessary for choosing appropriate pharmacologic therapies as well as the therapeutic agents themselves.